Overview

The fourth volume in the series covers the techniques and technologies involved in the preparation of semisolid products such as ointments, creams, gels, suppositories, and special topical dosage forms. Drug manufacturers need a thorough understanding of the specific requirements that regulatory agencies impose on the formulation and efficacy determination of drugs contained in these formulations. Highlights from Semisolid Products, Volume Four include: coverage of over 350 formulations valuable information on the difficult area of compliance changes to approved new drug applications and abbreviated new drug applications the evolving guidelines of ICH and when to conduct a regulatory review

Full Product Details

Author:   Sarfaraz K. Niazi (Pharmaceutical Scientist Inc., Deerfield, Illinois, USA)
Publisher:   Taylor & Francis Ltd
Imprint:   CRC Press
Edition:   2nd edition
Weight:   0.684kg
ISBN:  

9781032931319

ISBN 10:   1032931310
Pages:   370
Publication Date:   14 October 2024
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

REGULATORY ANDMANUFACTURING GUIDANCE: Waiver of In Vivo Bioequivalence Study. Quality Risk Management. Pharmaceutical Quality System. Pharmaceutical Development. Pharmaceutical Development in CTD. Scale-Up and Postapproval Changes for Nonsterile Semisolid Dosage Forms: Manufacturing Equipment. GOOD Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Validation of Analytical Procedures. Validation of Analytical Procedures: Methodology. Bioequivalence Testing of Topical Drugs. Good Manufacturing Requirements for Active Pharmaceutical Ingredients. FDA Active Pharmaceutical Ingredient Manufacturing Facility Inspection. Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. Skin Irritation and Sensitization Testing of Generic Transdermal Drug Products. Impurities in New Drug Substances. Impurities in New Drug Products. Formulation Factors in Semisolid Dosage Forms. GMP Audit Template, EU Guidelines. Dissolution Testing of Semisolid Dosage Forms. Approved Excipients in Semisolid Dosage Forms. MANUFACTURING FORMULATIONS: Regulatory and Manufacturing Guidance.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions